I came across an interview to Dr. Burt Berkson today and thought his work is brilliant. So I thought I'd revive this thread with some of what I've heard and what I could find elsewhere doing a fast search.
I can imagine that his work isn't new to the ones who have read the book Laura was recommending a long time ago at the beginning of this thread. And I can see that there is already some information posted here, so I don't want to repeat what is there already. So, I just want to say that listening to what he's been doing and the results he gets treating very serious liver diseases was inspiring and motivating.
He (and others who follow his work) were interviewed by Johnathan Landsman on his "
Fatty Liver Docu-class", and report complete reversal of liver disease in patients who were literally on a waiting line for liver transplant, or were so ill that were told there was no other option than to have some pain relievers and prepare to die. He also tells of his experience with the FDA, because he worked for them until they fired him for finding cures to serious conditions, which would of course affect pharmaceuticals. He also shares how he has been called to attend conferences at the National Cancer Institute in the US because he had been having great results for cancer treatment as well, and they even published a journal about it because his results are quite impressive, yet, most doctors are reluctant to use this with their own patients. I've found a publication here:
Dr. Berkson presented on his experience treating patients with alpha-lipoic acid (ALA) plus low-dose naltrexone (LDN) for various cancers and autoimmune diseases. The group also heard from Dr. Renee N. Donahue, Research Fellow in the Laboratory of Tumor Immunology and Biology at the NCI Center for Cancer Research, about her pre-clinical research on the efficacy and proposed mechanism of action of LDN for the treatment of cancer.
[...]
Dr. Berkson presented seven case reports on patients with advanced cancers (pancreatic and lymphomas) that he had treated over the past 10 years with a combination of ALA (intravenously and orally) and LDN (orally), along with diet, vitamins, and lifestyle changes. Earlier in his medical career, Dr. Berkson reported success using ALA to repair liver damage in patients from mushroom poisoning or chronic infections with hepatitis C virus. He also cited a number of research articles in European medical journals showing ALA’s beneficial effects on cancer.
Dr. Berkson learned about the use of LDN for treating cancer from a patient with advanced prostate cancer. He reported to Dr. Berkson after the successful therapy with LDN of both the patient’s cancer and rheumatoid arthritis (RA). Subsequently, Dr. Berkson offered LDN to his patients with RA and other autoimmune diseases. “Within about a month, most of the patients were off all drugs and feeling completely normal on just LDN, at $15 a month,” he recalled. [...]
Now, that's super interesting! In the interview, he said he uses
high doses of IV Vitamin C, which is also discussed in this
thread (where some people also mentioned a bit about ALA),
in the morning, and then
IV Lipoic Acid in the afternoon, and this helps not only regenerate the body but also recycle some of that morning Vitamin C to make it more effective. And yes, he also uses low-dose naltrexone (which is a prescription drug about which I don't know much at the moment, but has been mentioned a few times in the
autoimmune conditions and infections thread).
As usual, I still have to read more and look for more references, but I thought I'd bring it up for those who have never heard of this doctor or maybe for those who may be interested in looking at his work on cancer/liver disease/autoimmune disease treatment. As others have posted here, there may be some things to consider when taking ALA (such as Candida overgrowth issues), yet, it seems to be a pretty basic substance that can help the body A LOT, and the good news is that it's very good when taken orally when it isn't such a serious condition. They do mention that the quality of the product is very important regarding ALA. They didn't mention a particular brand but said that what works best for them ALA manufactured in Germany or Italy. And they also said that it is important to take B vitamins when taking ALA and that it can have an impact on blood sugar, so diabetics may need to be a little extra careful with it. But overall, it seems rather safe.
Here's one of the stories he usually tells:
I had been working with intravenous alpha lipoic acid (IV ALA) for many years; we did the first human clinical studies at the United States’ National Institutes of Health back in the 1970’s. I always thought that would be a good treatment for cancer because it floods cancer cells with oxygen and they tend to die (are forced into an anaerobic metabolism). So I was interested in that, and then when I learned about LDN, I thought I’d combine the two. Then
a man came to see me who had pancreatic cancer which had spread to the liver. A big university hospital told him there was no hope and there was nothing else that could be done. He was only 46 years old, had no bad habits, and was basically a healthy man. I asked him if he’d like to try this combination treatment and he agreed. So we gave him the IV ALA and LDN. Within 2 months he went back to work and his disease was non-progressive and symptom-free more than 3 years later (as opposed to most patients with this cancer who succumb to their disease within 6 months after a very painful course). So I wrote up
the case and it was published in Integrative Cancer Therapies.
Dr. Burton Berkson, an integrative physician from New Mexico, relates his vast experience with LDN in treating pancreatic cancer and autoimmune disease.
www.ldnscience.org
Here's the case in detail:
The Long-term Survival of a Patient With Pancreatic Cancer With Metastases to the Liver After Treatment With the Intravenous -Lipoic Acid/Low-Dose Naltrexone Protocol
Subscription and open access journals from SAGE Publishing, the world's leading independent academic publisher.
journals.sagepub.com
And here's a more recent case too:
In this case report, we describe the treatment of a 64-year-old male patient diagnosed with metastatic renal cell carcinoma (RCC) in June of 2008. In spite of a left nephrectomy and the standard oncological protocols, the patient developed a ...
www.ncbi.nlm.nih.gov
And this one seems to be his website:
Integrative Medical Center